Bildkälla: Stockfoto

Bioextrax: Sweet dreams of a bright 2024 - VH Corp

* Joint Development Agreement with the candy producer in Q1
* Progression in several projects, funding risk remains
* Our model implies a fair valuation of SEK 7.60 per share

A quiet final quarter of 2023 was followed by an eventful start of 2024 for
Lund-based Bioextrax. In January, the American startup terminated the contract
due to financial issues. For Bioextrax, the financial impact of the
cancellation was limited according in our valuation model. However, the stock
market reaction on the news was harsh sending the share price down by 30 per
cent.
Börsvärldens nyhetsbrev
ANNONSER